Semaglutide's Multi-Organ Benefits in Type 2 Diabetes Stem from Broad Molecular Adaptations Across Inflammatory, Lipid, and ECM Pathways
The systems medicine view of semaglutide: from clinical trials to molecular mechanisms.
Abstract
A comprehensive review details how semaglutide improves glycemic control, weight, and cardiovascular health by modulating inflammatory, lipid, and extracellular matrix pathways.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
